1/248
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
immunity
organized series of actions by body to protect itself against pathological organism - resulting in destruction/neutralization of organism
fx of immune system
homeostasis, defense, surveillance
foreign substances (antigens)
bacteria, viruses, fungi, prions, parasites
haptens
smallest molecules in body; ppl have different systems
antigens
have receptor sites (what’s attached within my immune system; memory cells are built)
cells involved w immune sys
mononuclear phagocytes, lymphocytes, dendritic cells, cytokines
lymphocytes involved in immune sys
B (bursa cells), T (t cytotoxic (CD8) and t helper (CD4), and natural killer
types of immunity
innate or acquired
innate/natural immunity
exists without former antigen contact; “born w it” (human specific immunity), includes natural barriers (skin, mucus membs), involves inflamm response; NON SPECIFC
active acquired immunity
when body responds to patho org and produces antibodies against them; follows an invasion and results in sensitized antibodies; when reinvaded response is faster; can take a while to develop but lasts long time (example: vaccines)
passive acquired immunity
temporary; receives antibodies to antigen instead of making them; quick but doesn’t last long bc no memory cells; (ex: immunoglobulin from mom to fetus; injection of serum antibodies)
types of immune response
humoral and cell-mediated
humoral immunity
antigen invades causes B cells to divide and become plasma cells (differentiated B) which produce antibodies (immunoglobulin) that travel in bloodstream to communicate w other cells
humoral immunity response
primary takes 4-8 days after initial exposure; 2nd exposure takes 1-3 days (stronger, longer lasting)
cell mediated immunity
when T cells recognize antigen and start immune response; production of sensitized t-lymphocytes to kill and destroy pathologic organisms
protection from cell-mediated immunity primarily against
cancer cells, virus infected cells, fungal infections; rejection of transplanted tissue, contact hypersensitivity reactions
immuno effects on aging
decrease in fx, increase infection susceptibility, alterations in T cells, increase tumor incidence, immunity from vax may not be as strong
overacting immune response
hypersensitivity disorders; alleriges, autoimmune disorders
under responsive immune sys
severe infections, immunodeficiency diseases, malignancies
overacting classifications
Type I, II, III, IV; can’t practice self-limitation
type I classification (overact immune resp)
IgE-mediated
type II classification (overact immune resp)
cytotoxic reaction
type III classification (overact immune resp)
immune-complex reaction
type IV classification (overact immune resp)
delayed hypersens reaction
type I IGE mediated reaction
chemical mediators released from mast cells: histamine, serotonin, leukotriene, eosinophil chemotactic factor, kinins, bradykinin; symptoms: increase mucosal secretion, itching, increased vas permeability, smooth mus contraction
anaphylaxis
med emergency!, shock can occur, tx: remove trigger, maintain airway, high flow oxygen, maintain circulatory vol, IV access, epi, albuterol, corticosteroids, diphenhydramine
type II cytotoxic reaction
target cells usually red, white, and platelets; commonly involved antigens: ABO blood group, Rh factor and drugs
if pt is transfused w incompatible blood
antibodies immediately coat foreign RBCs, RBCs agglutinate, life threatening, cell lysis and possible renal failure secondary to hemoglobinuria
collab care of hypersens reactions
after allergy dx: avoid trigger/allergen, tx symptoms, desensitization through immunotherapy if necessary; document allergies, drug therapy
durg therapy for chronic allergies
antihistamines, sympathomimetic/decongestant drugs, corticosteroids, topical antipruritics, mast cell-stablizing drugs
sympathomimetic/decongestants
epinephrine (adrenalin), pseudoephedrine (sudafed)
corticosteroids
most commonly given nasally
topical antipruritic drugs
calamine lotion
mast-cell stabilizing drugs
cromolyn, nedocromil (both aval as nasal spray/inhalant neb); these don’t help immediately
latex allergies
the longer one uses, more likelihood of getting allergy; two types: IV and I; symptoms include skin rash, hives, itching, nasal/eye/sinus s/s, asthma, and shock
type I latex allergy
minutes of contact
type IV latex allergy
contact dermatitis, delayed reaction: up to 6-48 hr
autoimmunity
immune resp attacks itself bc it cannot tell self from non-self (no self-recognition); unknown cause, classified by organ and systemic diseases; tx: aphaeresis
apheresis
procedure where blood components are separated then one of those components are removed; ex: plasmapheresis - watch for hypotension and citrate toxicity
autoimmune issues
occur anywhere; known as having flare ups and remissions & our job as nurse is to try and keep pts in remission
immunodeficiency disorders
occurs when immune sys doesn’t provide adequate protection to body; one or more immune mechs impaired; primary and secondary disorders
primary immunodeficiency disorder
improperly developed/absent immune cells
secondary immunodeficiency disorder
caused by illness or tx
causes of secondary immunodeficieny
drug-induced, age, malnutrition, stress, diseases/disorders, therapies
vax
contain small amts of pathogenic organism (alt so it doesn’t cause disease) ATTENUATED VS NONATTENUATED
vax work
admin to pt, pt produces antibodies, later if pt is exposed to pathogen body can get rid of it; pt is protected from disease, hopefully, without ever having it
precautions/contrainds for adult vax
hx of anaphylactic reac, immunocomp state, pt w febrile illness, allergy to eggs
vax contraind in preg
LAIV, MMR, VAR, AND ZVL
dont give attenuated vax
to ppl who disqualify themselves (pregnant women)
type I HIV
prev in US and canada; more responsive to drugs
type II HIV
more prev in 3rd world countries; more resistant
HIV modes of transmission
sexual, blood, perinatal (during preg and birth, breastfeeding)
¼ babies of HIV+ moms
will get virus (all will have antibodies)
incidence of HIV
33 million worldwide; 1 mil in US; ~50,000 new each year; msot are men
HIV and RNA
has rna but no dna so must have host cell to duplicate; attaches to gp120 knobs to cell’s CD4 receptors
cells w CD4 receptors
T helper, lymphocytes, and monocytes
inside HIV
rna makes viral dna with reverse transcriptase; viral dna enters cells dna and alters; infected immune cell makes HIV infected cells
acute HIV infection
develop HIV specific antibodies; occurs 1-3 weeks post infec.; lasts 1-2 weeks; headaches, body aches, diarrhea, pharyngitis, etc; viral load rises quickly
chronic infection HIV
asymptomatic & symptomatic, AIDS
chronic asymptomatic inf (HIV)
also called latent phase; 1-2 months-8years; viral load bt 200-500, CD4 counts maintains above 500 cells/ul; intense disease proliferation
chronic symptomatic infection
early symptomatic phase; from year 8-year10; CD4 t-cells bt 200-500; s/s: night sweats, fever, chronic diarrhea, headaches, fatigue, thrush, kaposi sarcoma, etc
chronic infection - AIDS
year 10+; CD4 below 200; opportunistic infections - (PJP), cryptococcal meningitis, cytomegalovirus retinitis; opportunistic cancers, wasting syndrome, dementia
rapid screening for HIV
OraSure (uses gum line), OraQuick (drop of blood), both 20 min screens, positives in either require EIA confirmation
testing for HIV
based on risk factors, 4th gen testing for both antigens and antibodies; 10 day eclipse or window period; immunoassay testing
test for HIV progression
measure CD4 counts and viral loads; CD4 norm between 800-1200 (w/o disease), viral load 200-500 means early chronic phase stable; high viral 5000-10,000 progressing
drug therapy
antiretroviral agents (ARTS), drugs to tx opportunistic infections
ARTs
NRTIs (nucleoside reverse transcrip inhibs), NNRTIs (non-neucleoside …) , protease inhibitors, integrase inhibitors, fusion inhibitors
goals for drug therapy
decrease viral load; maintain or raise CD4 counts, delay dev of HIV related symptoms and opportunistic diseases
PrEP (pre-exposure prophylaxis) drugs
prescribed to ppl at risk for HIV; to prevent HIV from sexor injection drug use; work by prevent integration to CD4
PrEPs reduce
risk of getting HIV from sex by abt 99% when taken as prescribed; reduces risk of getting HIV by at least 74% (truvada (men & women) and descovy (men))
PEP (post-exposure preophylaxis)
med to prevent HIV after possible exposure; must be within 72 hrs exposure, for emergent situations (not repeated expos), combo of 3 ART meds for 28 days; CDC rec tenofovir, emtricitabine, and raltegravir or dolutegravir
valves of heart are
unidirectional
heart valves
tricuspid, pulmonic, mitral, aortic
coronary circulation
has own circ sys; blood flows during diastole, systolic = max pressure
sinuses of valsava
right above cusps of aortic valve; open into right and left cor art
right coronary artery
supplies r atrium and r ventricle (part of posterior left vent)
left coronary artery
branches into left anterior descending and left circumflex artery that supply the left atrium and left ventricle
ischemia
tissue hypoxia; inadequate blood flow to meet myocardial o2 requirements; pain that goes along w it is angina
myocardial infarction (MI)
result of permanent loss of blood supply and cellular death (tissue necrosis)
SA node
specialized nerve tissue - heart’s pacemaker; drives heart beat
action potential
electrical impulse travels through heart and leads to contraction; all cardiac muscle has this (start of heart beat)
contraction
occurs when calcium flows into cardiac cells after depolarization
depolarization
calcium coming out of cell
AV node
allows time for atria to fill by providing break in contraction
bundle of his
picks up impulse and spreads it over ventricles by way of purkinje fibers
repolarization
cells return to former state
systole
absolute refractory period during which cardiac muscle gradually recovers and is excitable again; opening of aortic valve
p wave
depolarization of atrium
PR interval
measure of time required for impulse to spread from SA node to ventricle
QRS interval
depolarization of the ventricles
t wave
repolarization of ventricles
EKG strip small box
0.04 sec
EKG large box
0.20 sec
p wave normal
0.06-0.12 sec
pr interval
0.12-0.20
QRS complex
0.04-0.12
p to p
to measure atrial rate
r to r
for ventricular rate
measure rhythm
regular, irregular, regular irregularity
rule of 10s
count each 6 sec strip for number of complexes then x10 for 60 secs